Inhibition of MLL1-menin interaction attenuates renal fibrosis in obstructive nephropathy

Jianan Zou1,2, Chao Yu3, Chunyun Zhang1

  • 1Department of Medicine, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

Insights

Disrupting the Mixed Lineage Leukemia 1 (MLL1)-menin interaction reduces kidney fibrosis by inhibiting partial epithelial-mesenchymal transition (EMT) and renal fibroblast activation.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Epigenetics

Background:

  • Mixed Lineage Leukemia 1 (MLL1) is a histone methyltransferase crucial for gene regulation.
  • The interaction between MLL1 and menin is essential for MLL1's enzymatic activity.
  • The role of MLL1-menin interaction in renal fibrosis, epithelial-mesenchymal transition (EMT), and fibroblast activation remains unclear.

Purpose of the Study:

  • To investigate the effect of inhibiting the MLL1-menin interaction on renal fibrosis.
  • To explore the impact on epithelial-mesenchymal transition (EMT) and renal fibroblast activation.
  • To elucidate the underlying mechanisms in a murine model and cell cultures.

Main Methods:

  • Utilized a unilateral ureteral obstruction (UUO) murine model of renal fibrosis.
  • Employed MI-503 to inhibit MLL1-menin interaction and siRNA for gene silencing.
  • Assessed expression of fibrosis markers (α-SMA, fibronectin), EMT markers (Snail, Twist, E-cadherin), and signaling pathways (Smad3, AKT) in kidney tissues and cultured cells.

Main Results:

  • Inhibition of MLL1-menin interaction attenuated UUO-induced renal fibrosis, α-SMA, and fibronectin expression.
  • Disruption of MLL1-menin interaction reduced Snail and Twist expression while preserving E-cadherin.
  • MI-503 and MLL/menin siRNA inhibited TGF-β1-induced profibrotic changes and myofibroblast transformation in vitro.

Conclusions:

  • Targeting the MLL1-menin interaction effectively attenuates renal fibrosis.
  • Inhibition of this interaction suppresses partial EMT and renal fibroblast activation.
  • Disrupting the MLL1-menin complex represents a potential therapeutic strategy for kidney fibrosis.